TurboGen reports $7.2M cash position, expects 2026 installations

TurboGen Ltd., based in Peta Tikva, Israel, has reported a significant improvement in its financial standing for the first half of 2026. As of June 30, 2026, the company held a cash position of $7.2 million, which is a substantial increase from $3.9 million at the end of 2025. This growth in cash reserves is attributed to an additional $5 million raised through a private placement in August 2026.

The company also reported a positive shareholders’ equity of $1.6 million as of June 30, 2026, representing a notable improvement of $4.7 million from the end of 2025. Despite generating no revenue during this period, TurboGen experienced a reduction in net loss, from $7.6 million in 2025 to $4.2 million in the current six-month period. This decline is primarily due to a $6.4 million favorable change in warrant fair value and debt extinguishment effects, although higher operating expenses have partially offset these gains.

However, the company did report an increase in operating loss, rising to $5.2 million from $2.3 million in the previous year, largely due to higher expenses. Research and development expenses saw a significant rise to $1.9 million, reflecting increased testing, materials, and contractor costs. General and administrative expenses also increased to $3.1 million from $1.4 million, primarily due to greater share-based compensation and professional expenses associated with the company's listing on the Nasdaq.

TurboGen completed the assembly of its first TR8000 model, an 80kW system, and has stated its expectation of conducting the first installations of microturbine systems, ranging from 32kW to 80kW, by the end of 2026. The company's ordinary shares began trading on Nasdaq on August 31, 2026, signaling further progress in its market presence. Net cash used in operating activities amounted to $2.7 million for this period, compared to $1.4 million in the prior-year period.